Although serum alpha-fetoprotein (AFP) was commonly used to diagnose and predict the prognosis of HCC, its clinical application is greatly compromised by the presence of many AFP-negative patients (AFP < 20 ng/mL) [5]. The gene discussed is AFP; the disease is hepatocellular carcinoma.